We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current BRNS market cap is 40.22M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 468k | 644k | -2k | 774k | 205k |
| Operating Income | -16.82M | -21.85M | -21.15M | -19.55M | -17.35M |
| Net Income | -18.18M | -23.8M | -14.07M | -17.29M | -15.49M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 600k | 45.27M | 1.88M |
| Operating Income | -40.89M | -2.58M | -79.37M |
| Net Income | -50.87M | 5.34M | -73.35M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 261.82M | 246.13M | 229.97M | 214.51M | 199.48M |
| Total Liabilities | 28.25M | 28.67M | 34.37M | 27.51M | 27.47M |
| Total Equity | 233.57M | 217.46M | 195.6M | 187M | 172.02M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 280.72M | 270.21M | 214.51M |
| Total Liabilities | 28.15M | 27M | 27.51M |
| Total Equity | 252.56M | 243.2M | 187M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -3.17M | -20.13M | -31.32M | -50.93M | -11.82M |
| Investing | -2.51M | -5.53M | -5.57M | -5.41M | -308k |
| Financing | 1.69M | 1.72M | 1.76M | 1.87M | 503k |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -32.58M | -14.43M | -50.93M |
| Investing | -12.91M | -5.75M | -5.41M |
| Financing | 222.74M | 325k | 1.87M |
| Market Cap | 40.22M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 40.23M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.07 (6.74%) |
| Company Name | Barinthus Biotherapeutics PLC |
| Address |
unit 6-10, zeus building oxfordshire OX11 0DF |
| Website | https://www.barinthusbio.com/ |
| Industry | offices-holdng companies,nec (6719) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
